ECOG-ACRIN EAA181: Effective quadruplet utilization after treatment evaluation (EQUATE)—a randomized phase 3 trial for newly diagnosed multiple myeloma (NDMM) not intended for early autologous transplantation
Recommended Citation
Kumar S, Wei Z, Thompson MA, et al. ECOG-ACRIN EAA181: Effective quadruplet utilization after treatment evaluation (EQUATE)—a randomized phase 3 trial for newly diagnosed multiple myeloma (NDMM) not intended for early autologous transplantation. Journal of clinical oncology. 2021;39:TPS8052-TPS8052.
Presentation Notes
Poster presented at: ASCO Annual Meeting 2021; June 2021; Chicago, IL
Document Type
Abstract
Affiliations
Aurora Cancer Care, Advocate Aurora Health